SC Filed 2019-10-17 Event — SEC 0001072613-19-000282 →

NEW ENTERPRISE ASSOCIATES 13 LP → Ra Pharmaceuticals, Inc.

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

9 13D/G filings on this issuer

8 other filings besides this one

Filer Track Record

6 filings by this filer

5 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other 13D/G Filings on Ra Pharmaceuticals, Inc.

Filed	Form	Filer	Stake	Shares
2020-04-06	SC	NEW ENTERPRISE ASSOCIATES 13 LP	—	—	view →
2019-10-11	SC	RA CAPITAL MANAGEMENT, LLC	—	—	view →
2019-03-08	SC	MORGENTHALER VENTURE PARTNERS IX LP	—	—	view →
2019-01-22	SC	MORGENTHALER VENTURE PARTNERS IX LP	—	—	view →
2019-01-07	SC	MORGENTHALER VENTURE PARTNERS IX LP	—	—	view →
2018-02-27	SC	NEW ENTERPRISE ASSOCIATES 13 LP	—	—	view →
2018-02-26	SC	Novo Holdings A/S	—	—	view →
2018-02-16	SC	RA CAPITAL MANAGEMENT, LLC	—	—	view →

Other Filings by NEW ENTERPRISE ASSOCIATES 13 LP

Filed	Form	Issuer	Stake	Shares
2023-07-07	SC	MINERVA SURGICAL INC	—	—	view →
2020-04-06	SC	Ra Pharmaceuticals, Inc.	—	—	view →
2019-07-08	SC	Epizyme, Inc.	—	—	view →
2019-01-30	SC	TESARO, Inc.	—	—	view →
2018-02-27	SC	Ra Pharmaceuticals, Inc.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →